Literature DB >> 4156293

Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man.

H B Hucker, S C Stauffer, S D White, R E Rhodes, B H Arison, E R Umbenhauer, R J Bower, F G McMahon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4156293

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN： 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  10 in total

1.  Effects of sodium naproxen on differentiated human chondrocytes cultivated in clusters.

Authors:  C Bassleer; Y Henrotin; P Franchimont
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

Review 2.  Clinical pharmacokinetics of sulindac. A dynamic old drug.

Authors:  N M Davies; M S Watson
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

Review 3.  Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-08       Impact factor: 9.546

4.  Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.

Authors:  M Schnitzler; T Dwight; B G Robinson
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

5.  Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.

Authors:  F M Giardiello; J A Offerhaus; A C Tersmette; L M Hylind; A J Krush; J D Brensinger; S V Booker; S R Hamilton
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

6.  Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system.

Authors:  Wei Zou; Sachin S Devi; Erica Sparkenbaugh; Husam S Younis; Robert A Roth; Patricia E Ganey
Journal:  Toxicol Sci       Date:  2008-12-12       Impact factor: 4.849

7.  Sulindac. Trials of a new anti-inflammatory drug.

Authors:  E C Huskisson; J Scott
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

8.  Sulphinpyrazone metabolism during long-term therapy.

Authors:  A K Pedersen; P Jakobsen
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

Review 9.  Sulindac and polyp regression.

Authors:  F M Giardiello
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

Review 10.  Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  R K Verbeeck; J L Blackburn; G R Loewen
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.